Balaji

Aspiring scientist.
Instructor in @mishabeltran's lab @DanaFarber.
@PCF_Science Young Investigator.
Tweets are mostly fictional :)

[Balaji @Bajji]

Excited to share our new 𝙉𝙖𝙩𝙪𝙧𝙚 𝘾𝙤𝙢𝙢𝙪𝙣𝙞𝙘𝙖𝙩𝙞𝙤𝙣𝙨 paper (collab b/w the @mishabeltran and @RickmanLab labs) revealing how Polycomb and DNA methylation cooperate to drive lineage plasticity in #ProstateCancer. Co-led with @Richa2807Singh.
https://t.co/hkOPzB0KTz

[UroToday.com @urotoday]

PROX1 explored as a driver of neuroendocrine #ProstateCancer progression. @Bajji @DanaFarber joins @AndreaMiyahira @PCFnews in discussing #PROX1 as an epigenetically derepressed driver in neuroendocrine prostate cancer. #WatchNow on UroToday > https://t.co/lyvCVSvfTG

[Misha Beltran @mishabeltran]

Excited to share our new paper @NatureComms in collaboration with @RickmanLab, led by #RichaSingh @WeillCornell and @Bajji @DanaFarber #BeltranLab

[Balaji @Bajji]

I was glad to join @AndreaMiyahira on the digital platform of @urotoday to discuss our recent publication in 𝘾𝙖𝙣𝙘𝙚𝙧 𝙍𝙚𝙨𝙚𝙖𝙧𝙘𝙝 from the #BeltranLab on PROX1 as a driver of neuroendocrine prostate cancer progression.
https://t.co/l10qh5daNi

@mishabeltran @PCF_Science

[Balaji @Bajji]

@alicebernardt @jclinicalinvest @mishabeltran Congrats, Alice!

[Bernard-Tessier @alicebernardt]

Just out today in @jclinicalinvest 🚀
mHSPC is not one disease, but a kaleidoscope of biological states. We highlight what we know — and the key gaps that remain — on the road to precision medicine✨
Led by my mentor @mishabeltran 🙌
#ProstateCancer #mHSPC #PrecisionOncology

[Balaji @Bajji]

Grateful for the chance to present at the #AACRprostate26 last week and honored to receive a 𝙎𝙘𝙝𝙤𝙡𝙖𝙧-𝙞𝙣-𝙏𝙧𝙖𝙞𝙣𝙞𝙣𝙜 𝘼𝙬𝙖𝙧𝙙.

I shared work from the #BeltranLab on epigenetic mechanisms of lineage plasticity in advanced prostate cancer.

[Balaji @Bajji]

Delighted to be invited to speak at the @DFCI_PGA Brain Lunch Seminar Series last week.
Presented our latest work from the @mishabeltran lab on epigenetic mechanisms of lineage plasticity in treatment-resistant prostate cancer.
Big thanks to the organizers for the invitation.

[Misha Beltran @mishabeltran]

Great lightening talks by Beltran Lab members Balaji and Jake presenting their latest work! #AACRProstate26 @DanaFarber_GU

[Dana-Farber Lank Center for Genitourinary Oncology @DanaFarber_GU]

A massive congratulations to two of our faculty members, Himisha Beltran (@mishabeltran) & Joaquim Bellmunt (@OncoBellmunt), who were promoted to Professor of Medicine at Harvard Medical School in December!

[Balaji @Bajji]

Many thanks to my mentor, @mishabeltran, for the opportunity to share the stage with my friend and colleague,@mkbakht, and present some of our latest unpublished work at the @DanaFarber Division of Molecular and Cellular Oncology Retreat 2025.

#BeltranLab

[Balaji @Bajji]

Congrats, @alicebernardt!
Well deserved!

#BeltranLab @PCF_Science

[Misha Beltran @mishabeltran]

Congratulations Dr Alice Bernard-Tessier ⁦@alicebernardt⁩ for receiving a PCF YIA! #proudmentor #BeltranLab ⁦@DanaFarber_GU⁩ @GustaveRoussy⁩ ⁦@PCF_Science⁩ ⁦@DrChoueiri⁩

[Balaji @Bajji]

Futuristic therapy for prostate cancer.
The sad prostate cancer cell is bombarded with combinatorial therapies.

#PCFYI
#PCFRetreat25 @PCF_Science @criscancer

[Balaji @Bajji]

Honored to receive the Michael O. Koch Award for Early Career Scholars at the Indiana University GU Cancer Symposium!

A huge thank you to @ClintCaryMD and @asmaakenawy for the invitation to present my work in the #BeltranLab. It was a privilege to meet Dr. Michael Koch himself!

[Balaji @Bajji]

I really enjoyed co-mentoring Arianny Mordan this summer, a talented student from the Workforce Development Program @DanaFarber. She gifted me a mug, but I’m too embarrassed to use it!
Excited to see all you’ll accomplish, Arianny!

Thanks to @mishabeltran for the support.

[Balaji @Bajji]

Thank you for the invitation to present, @PathfinderDFHCC!
Excited to discuss our recent work published in @CR_AACR at this 'micro' journal club where I'll summarize the paper in < 10 min, followed by a discussion.
Open to all. Register if interested!
@mishabeltran @DanaFarber_GU

[Balaji @Bajji]

Excited to share our new study in 𝘾𝙖𝙣𝙘𝙚𝙧 𝙍𝙚𝙨𝙚𝙖𝙧𝙘𝙝!
We focus on PROX1 as a key driver of neuroendocrine #ProstateCancer and highlight its potential as a therapeutic target.
Huge thanks to @mishabeltran for her mentorship!

https://t.co/0rfnsvFSUX

@PCF_Science @CDMRP

[Balaji @Bajji]

Thank you for highlighting our work published this week in @CR_AACR!

@mishabeltran

[Dana-Farber Lank Center for Genitourinary Oncology @DanaFarber_GU]

New research out from lead author @Bajji and senior author @mishabeltran on the role of transcription factor PROX1 in transformation into neuroendocrine prostate cancer. Out now in Cancer Research @CR_AACR #BeltranLab https://t.co/7j5bBC4d1a

[Balaji @Bajji]

Thank you for highlighting our work published in @CR_AACR!
@mishabeltran

[Dana-Farber News @DanaFarberNews]

Some prostate cancers evade therapy by transforming into aggressive neuroendocrine prostate cancer. New research highlights PROX1 as a key driver of this transformation and tumor growth, offering a potential treatment target.

➡️ https://t.co/KUL6C6c9LE

@CR_AACR @bajji @mishabeltran

[Balaji @Bajji]

Honored to give 2 talks last week at the Gordon: Hormone-Dependent Cancers!
Huge thanks to organizers for the invitation.
Special thanks to my mentor, @mishabeltran, for her incredible support.

Loved learning, sharing ideas, and feeling the warmth of this amazing #GRC community.